RxDoctor Payments Data

Amarendar Kasarla, MD

Anesthesiology · Lafayette, LANPI 1104813260

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 77 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Abbott at 36.7% of the total. Reporting peaked in 2021 at $553 and has fallen 55.1% since, to $249 in 2025. Among anesthesiology clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,279in general payments, 2019–2025

Across 77 payments — averaging $29.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$836
  • Medtronic$516
  • Nevro Corp.$215
  • Boston Scientific$208
  • Saluda Medical Americas, Inc.$128
  • Acacia Pharma Inc$105
  • plus $271 from 7 others

What the payments were for

  • Food & beverage$2,279100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,279 in reported general payments places this provider in the 90th percentile of 497 anesthesiology providers in Louisiana.

See all anesthesiology providers in Louisiana

Medicare billing

Part B allowed, 2024
$87,497
Medicare patients
212
Services billed
855

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen926$24,037
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen446$12,805
Oxycodone Hcl471$12,617
MovantikNaloxegol Oxalate30$11,674
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc51$6,371
Fentanyl65$4,835
Gabapentin481$4,402
Lidocaine-PrilocaineLidocaine/Prilocaine71$4,245
OxycontinOxycodone Hcl11$3,461
Lidocaine56$3,342
Morphine Sulfate ErMorphine Sulfate138$3,248
Tizanidine Hcl289$2,648
Pregabalin164$2,492
Diclofenac Sodium75$2,315
Tramadol Hcl217$1,520

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Lafayette

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →